Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

CP Kelco UK Ltd

CP Kelco is the innovation leader in the production of polysaccharides by microbial fermentation, extraction from land and sea plants, and modification of cellulose-based raw materials. CP Kelco’s goal is to be the preferred partner for providing innovative products and solutions through the use of nature-based chemistry.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

CP Kelco UK Ltd
Cleeve Court, Cleeve Road, Leatherhead, Surrey, KT22 7UD
+44  (0) 1372 369 400
Contact CP Kelco UK Ltd
Website

 Latest Content from PMHub 

Research Partnership has published a new Living with Chronic Pain market report for 2016

White Papers and Resources | November 23, 2016 | Inizio

Chronic pain is defined as pain lasting longer than 6 months and affects 100 million Americans. Living with Chronic Pain is a quantitative study conducted online amongst 390 US patients...

Nutraceuticals: Rich in Potential

White Papers and Resources | November 23, 2016 | Inizio

Published in eyeforpharma October 2016 by Marc Yates

Case Study: Qualitative research with payers in low and middle income countries

White Papers and Resources | November 23, 2016 | Inizio

Our client wanted to understand in detail the usage decision drivers, triggers and processes for a high-cost innovative Acute Heart Failure (AHF) drug used in the acute emergency setting in...

Webinar – Immuno-oncology’s Evolution: Implications for Pharma Market Researchers

White Papers and Resources | November 23, 2016 | Inizio

In association with PMGroup

Case study: Leveraging Market Research Data to Inform Healthcare Providers and the Community

White Papers and Resources | November 23, 2016 | Inizio

Our client wanted to understand why uptake of HPV vaccination in the Asia-Pacific region was limited.  In order to help increase uptake, they wanted to publish the market research findings...

Towards a culture of evaluation and evidence-based decision making in global health

White Papers and Resources | November 23, 2016 | Inizio

Reflections on THET Conference 2016: Evidence, Effectiveness & Impact

Research Partnership has published a new Living with Ulcerative Colitis (UC) market report for 2016

White Papers and Resources | November 23, 2016 | Inizio

Ulcerative Colitis (UC) is a progressive and debilitating disease which affects between 2.5 to 3 million people in Europe. Living with UC is a quantitative study conducted online amongst 325 patients, including...

The Internet of Things

White Papers and Resources | November 23, 2016 | Inizio

Evolution from man to machine

Therapy Watch expands its oncology portfolio

White Papers and Resources | November 23, 2016 | Inizio

This month Therapy Watch Oncology will be expanding its portfolio with the addition of Squamous Cell Carcinoma of the Head and Neck (SCCHN). Therapy Watch SCCHN is part of a wider portfolio...

Time for a new language for asthma?

White Papers and Resources | November 23, 2016 | Inizio

Despite the global advances made in the treatment for asthma, many studies have shown that asthma remains uncontrolled for a large proportion of patients, when assessed according to international guidelines....